Denmark · Delayed Price · Currency is DKK RTX A/S Earnings Call Transcripts
Fiscal Year 2026
-
Q1 saw 7% revenue growth to DKK 108 million, driven by strong Healthcare and ProAudio performance, with gross margin rising to 55%. Full-year guidance is maintained, supported by a robust order book and positive market trends in key segments.
Fiscal Year 2025
-
Revenue grew 10% year-over-year with improved gross margin and strong liquidity, driven by enterprise and healthcare segments. Outlook projects further growth and profitability, with continued investments in healthcare, retail, and next-gen platforms.
-
Revenue and profitability grew in Q3, led by enterprise and healthcare, despite currency headwinds. Guidance was raised and narrowed, with strong liquidity enabling a share buyback. ProAudio is transitioning to a scalable model, and supply chain diversification continues.
-
Revenue and gross margin improved year-over-year, led by Enterprise growth and a strategic shift to modules in ProAudio. Healthcare faced delays but expects solid growth as new products launch. Gross margin set a new baseline at 51%, with robust liquidity and equity.
Fiscal Year 2024
-
Q3 saw sequential revenue and gross margin improvement, but overall demand remains subdued due to high customer inventories and macroeconomic headwinds. Full-year guidance is maintained, with normalization expected over the next 12 months, though visibility remains low.